Immediate Impact
20 standout
Citing Papers
Inflammation in cancer: therapeutic opportunities from new insights
2025 Standout
The hallmarks of cancer immune evasion
2024 Standout
Works of Shaoyuan Wang being referenced
Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Chronic Myelomonocytic Leukemia (CMML)
2023
DHX15 is associated with poor prognosis in acute myeloid leukemia (AML) and regulates cell apoptosis via the NF-kB signaling pathway
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Shaoyuan Wang | 116 | 47 | 45 | 50 | 42 | 229 | |
| Szymon Zmorzyński | 113 | 53 | 33 | 51 | 37 | 266 | |
| Toyotaka Kawamata | 69 | 73 | 78 | 52 | 30 | 231 | |
| Amr Hanbali | 104 | 94 | 29 | 67 | 43 | 285 | |
| Jiadai Xu | 139 | 100 | 49 | 43 | 42 | 272 | |
| Ling Pan | 157 | 104 | 30 | 33 | 31 | 297 | |
| Juan Luiz Coelho‐Silva | 153 | 75 | 25 | 50 | 34 | 254 | |
| Weiying Gu | 94 | 53 | 52 | 36 | 33 | 227 | |
| Lijun Zhang | 103 | 91 | 32 | 23 | 32 | 253 | |
| Céline Bourgne | 104 | 41 | 24 | 34 | 26 | 257 | |
| Jean‐Baptiste Gibier | 107 | 19 | 29 | 50 | 36 | 232 |
All Works
Login with ORCID to disown or claim papers
Loading papers...